Ciprofloxacin-associated Peripheral Neuropathy in a Child: A Case Report and Review of the Literature.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
pubmed:
25
11
2021
medline:
15
2
2022
entrez:
24
11
2021
Statut:
ppublish
Résumé
Fluoroquinolones are reported to have peripheral nerve toxic effects that can be severe and permanent in adults. However, limited data exist for children. We describe a case of acute-onset peripheral neuropathy associated with ciprofloxacin in a 13-year-old boy who was characterized by severe dysesthesia and erythema of both hands and feet, but which resolved promptly after ceasing the antibiotic.
Identifiants
pubmed: 34817415
doi: 10.1097/INF.0000000000003373
pii: 00006454-202202000-00007
doi:
Substances chimiques
Anti-Bacterial Agents
0
Ciprofloxacin
5E8K9I0O4U
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121-122Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Bennett AC, Bennett CL, Witherspoon BJ, et al. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency. Expert Opin Drug Saf. 2019;18:1055–1063.
Ali AK. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis. Ann Epidemiol. 2014;24:279–285.
Cohen JS. Peripheral neuropathy associated with fluoroquinolones. Ann Pharmacother. 2001;35:1540–1547.
Hedenmalm K, Spigset O. Peripheral sensory disturbances related to treatment with fluoroquinolones. J Antimicrob Chemother. 1996;37:831–837.
Dixit A, Karandikar MV, Jones S, et al. Safety and tolerability of moxifloxacin in children. J Pediatric Infect Dis Soc. 2018;7:e92–e101.
Jackson MA, Schutze GE; COMMITTEE ON INFECTIOUS DISEASES. The use of systemic and topical fluoroquinolones. Pediatrics. 2016;138:e20162706.
Morales D, Pacurariu A, Slattery J, et al. Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy. JAMA Neurol. 2019;76:827–833.
Karol SE, Sun Y, Tang L, et al. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia. Cancer Med. 2020;9:6550–6555.
Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol. 2019;44:477–482.
Jumma OK, Dick J, Marshall A, et al. Ciprofloxacin induced acute small fibre neuropathy. Case report. Can J Neurol Sci. 2013;40:127–128.